To address medicine shortages and supply chain disruptions, this project introduces an agile manufacturing platform for pharmacies and hospital pharmacies. Using 3D-inspired robotic dosing, AI-driven analytics, RFID tracking, and workflow automation, the system ensures real-time, scalable, and regulatory-compliant production of essential medicines. By decentralising pharmaceutical manufacturing, it enables rapid responses to crises, reduces bottlenecks and waste, and enhances EU healthcare resilience.
- Beneficiaries
Coordinators: Curifylabs OY
Participants: AtrimusRx AB - Fysioline Oy - Pharmacie Delpech - Sihtasutus tartu ulikooli kliinikum - Universitaetsmedizin der Johannes Gutenberg-universitaet Mainz - Vaasan Hietalahden apteekki
- Project Locations
Finland - Sweden - France - Estonia - Germany
- EU contribution
€ 3.36 million
- Funding sources
Explore EU innovative projects awarded the STEP Seal. View projects’ details, funding status, and connect with promoters via the interactive dashboard.
Other STEP stories on biotech
In Warsaw, STEP is supporting a pioneering gene therapy for Parkinson’s disease, helping strengthen Europe’s leadership in biotechnology and advanced medical research.
What if diagnosis could be faster, more precise and tailored to each patient? O-MAI is combining AI, imaging and omics sciences to help shape the future of personalised medicine in Europe
PharmSD 3.0 will develop an integrated, continuous-pharmaceutical spray drying process to enhance efficiency, scalability, and cost-effectiveness.